122 related articles for article (PubMed ID: 38272394)
21. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
Tas F; Erturk K
Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.
Carrera C; Gual A; Díaz A; Puig-Butillé JA; Noguès S; Vilalta A; Conill C; Rull R; Vilana R; Arguis P; Vidal-Sicart S; Alós L; Palou J; Castel T; Malvehy J; Puig S
Melanoma Res; 2017 Aug; 27(4):315-320. PubMed ID: 28296711
[TBL] [Abstract][Full Text] [Related]
23. "Gloves-and-socks" melanoma: does histology make a difference?
Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
25. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
[TBL] [Abstract][Full Text] [Related]
26. Acral Lentiginous Melanoma: Survival Analysis of 715 Cases.
Lino-Silva LS; Zepeda-Najar C; Salcedo-Hernández RA; Martínez-Said H
J Cutan Med Surg; 2019; 23(1):38-43. PubMed ID: 30221995
[TBL] [Abstract][Full Text] [Related]
27. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
[TBL] [Abstract][Full Text] [Related]
28. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
29. Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
Wade RG; Robinson AV; Lo MCI; Keeble C; Marples M; Dewar DJ; Moncrieff MDS; Peach H
Ann Surg Oncol; 2018 Oct; 25(11):3341-3349. PubMed ID: 30066226
[TBL] [Abstract][Full Text] [Related]
30. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
Lim Y; Lee J; Lee DY
J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
[TBL] [Abstract][Full Text] [Related]
31. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.
Tas F; Erturk K
Am J Dermatopathol; 2022 Nov; 44(11):799-805. PubMed ID: 35925149
[TBL] [Abstract][Full Text] [Related]
32. Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
Davis JL; Langan RC; Panageas KS; Zheng J; Postow MA; Brady MS; Ariyan C; Coit DG
Ann Surg Oncol; 2017 Jul; 24(7):1989-1996. PubMed ID: 28303429
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.
Lee TL; Liao YH; Liau JY; Sheen YS
Sci Rep; 2021 Oct; 11(1):21012. PubMed ID: 34697327
[TBL] [Abstract][Full Text] [Related]
35. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
36. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
[TBL] [Abstract][Full Text] [Related]
37. The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study.
Robinson AV; Keeble C; Lo MCI; Thornton O; Peach H; Moncrieff MDS; Dewar DJ; Wade RG
Cancer Immunol Immunother; 2020 Apr; 69(4):559-568. PubMed ID: 31974724
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
39. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients.
Teramoto Y; Keim U; Gesierich A; Schuler G; Fiedler E; Tüting T; Ulrich C; Wollina U; Hassel JC; Gutzmer R; Goerdt S; Zouboulis C; Leiter U; Eigentler TK; Garbe C
Br J Dermatol; 2018 Feb; 178(2):443-451. PubMed ID: 28707317
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
